C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2011
03/17/2011	WO2011032166A2 Reprogramming blood cells to pluripotent and multipotent stem cells
03/17/2011	WO2011032124A1 Compositions and methods for recovery of nucleic acids or proteins from tissue samples fixed in cytology media
03/17/2011	WO2011032112A2 Mutant sodium channel nav1.7 and methods related thereto
03/17/2011	WO2011032100A1 Inhibitors of kshv vil6 and human il6
03/17/2011	WO2011032054A2 Analysis of y-chromosome str markers
03/17/2011	WO2011032045A1 Modulation of huntingtin expression
03/17/2011	WO2011032025A2 Adipose-derived induced pluripotent stem cells
03/17/2011	WO2011031998A1 Modulation of re1 silencing transcription factor expression
03/17/2011	WO2011031897A1 Microorganisms and methods for the co-production of isopropanol with primary alcohols, diols and acids
03/17/2011	WO2011031835A1 Chimeric dr5 polypeptides and uses thereof
03/17/2011	WO2011031769A2 Methods for risk assessment, treating, and diagnosing myocardial infarction
03/17/2011	WO2011031680A1 Enhancement of plant yield, vigor and stress tolerance ii
03/17/2011	WO2011031568A2 A NOVEL PROTEIN DELIVERY SYSTEM TO GENERATE INDUCED PLURIPOTENT STEM (iPS) CELLS OR TISSUE-SPECIFIC CELLS
03/17/2011	WO2011031520A1 Composition for inhibiting gene expression and uses thereof
03/17/2011	WO2011031482A2 Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap
03/17/2011	WO2011031477A2 Nucleolin-binding peptides, nucleolin-binding lytic peptides, fusion constructs and methods of making and using same
03/17/2011	WO2011031471A2 The fungal srebp pathway as a target for anti-fungal agents
03/17/2011	WO2011031467A1 Anti-cancer therapeutic strategy to overcome cancer resistance and to enable tailoring treatment to patients
03/17/2011	WO2011031438A2 Porcine torque teno virus vaccines and diagnosis
03/17/2011	WO2011031370A1 Enhancement of reproductive heat tolerance in plants
03/17/2011	WO2011031319A2 Rnai in budding yeast
03/17/2011	WO2011031141A1 Method for improving flavor production in a fermented food product
03/17/2011	WO2011031127A1 Method for isolating dna
03/17/2011	WO2011031006A2 Cabbage-moth-resistant cabbage transformed by the cryiac gene, and method for producing same
03/17/2011	WO2011030964A1 Composition for atp synthesis, mounted for gloeobacter rhodopsin and atp synthase to have orientation
03/17/2011	WO2011030838A1 Method for analyzing nucleic acid mutation using array comparative genomic hybridization technique
03/17/2011	WO2011030825A1 Culture method for hematopoietic stem cells
03/17/2011	WO2011030823A1 Carrier for holding nucleic acids
03/17/2011	WO2011030793A1 Use of gene involved in taking-in of aluminum into plants
03/17/2011	WO2011030724A1 Use of gene involved in accumulation of cadmium in plants
03/17/2011	WO2011030682A1 Construct coated with virus coat-constituting protein and method for producing same
03/17/2011	WO2011030347A1 Novel prolipase-bovine trypsinogen fusion proteins
03/17/2011	WO2011030329A1 Method of treating tumors
03/17/2011	WO2011030083A1 Method
03/17/2011	WO2011029931A1 Composition for treatment of cxcl8-mediated lung inflammation
03/17/2011	WO2011029869A1 Hypoallergenic hybrid polypeptides for the treatment of allergy
03/17/2011	WO2011029798A1 Composition and method for imaging stem cells
03/17/2011	WO2011029696A1 Directed evolution of arginine deiminase for increased activity at physiological ph
03/17/2011	WO2011011568A8 Methods and compositions for the production of fatty acids in photosynthetic prokaryotic microorganisms
03/17/2011	WO2011011061A3 Method of regulating angiogenesis and lymphangiogenesis, and a pharmaceutical composition for effecting anti-angiogenic and anti-lymphangiogenic cancer therapy
03/17/2011	WO2011001294A3 Viral sequence involved in the regulation of gene expression, expression vector, cell and plant containing same
03/17/2011	WO2011001286A3 Expression of transcription regulators that provide heat tolerance
03/17/2011	WO2011001247A3 Methods and kits for high efficiency engineering of conditional mouse alleles
03/17/2011	WO2011001086A3 Use of interfering rna for treating an hiv infection
03/17/2011	WO2011000933A3 Enhanced phytase variants
03/17/2011	WO2010136841A3 Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof
03/17/2011	WO2010129784A3 Isolated a-type fhf n-terminal domain peptides and methods of use
03/17/2011	WO2010122367A3 Meganuclease variants cleaving the genomic insertion of a virus and uses thereof
03/17/2011	WO2010120508A3 Regulation of mir-33 micrornas in the treatment of cholesterol-related disorders
03/17/2011	WO2010118188A3 Production of an intact virus in a non-host cell system using a secondary host viral construct
03/17/2011	WO2010110599A9 Novel αlpha-neoagarobiose hydrolase, and method for obtaining a monosaccharide using same
03/17/2011	WO2010082097A4 Fusion proteins the process to preparation and utilization in expression systems of recombinant proteins
03/17/2011	WO2010071608A9 Genetic transformation of jatropha curcas
03/17/2011	US20110067148 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
03/17/2011	US20110067147 Development of Very Early Flowering and Normal Fruiting Plum With Fertile Seeds
03/17/2011	US20110067146 Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases
03/17/2011	US20110067145 Specific Promoter Region Expresses in Actively Dividing Young Tissues and the Aging Tissues in Plants as Well as its Application
03/17/2011	US20110067144 Method for creating broad-spectrum resistance to fungi in transgenic plants
03/17/2011	US20110067142 Hybrid artichoke variety nun 4006 ar
03/17/2011	US20110067139 Soybean Cultivar S080188
03/17/2011	US20110067138 Soybean Cultivar 8533440
03/17/2011	US20110067137 Soybean Cultivar 8615185
03/17/2011	US20110067136 Soybean Cultivar 8201155
03/17/2011	US20110067125 Method for producing founder animal for reproducing animal having lethal phenotype caused by gene modification
03/17/2011	US20110067124 Detection and treatment of drug associated angioedema
03/17/2011	US20110067122 Expression of Xenogenous (Human) Immunoglobulins in cloned, transgenic ungulates
03/17/2011	US20110067121 Transgenic mice having a human major histocompatibility complex (MHC) phenotype, experimental uses and applications
03/17/2011	US20110065908 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
03/17/2011	US20110065898 Immunosuppressant Target Proteins
03/17/2011	US20110065779 Aav vector compositions and methods for enhanced expression of immunoglobulins using the same
03/17/2011	US20110065778 RNA Interference Mediated Inhibition of Muscarinic Colinergic Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA)
03/17/2011	US20110065777 DOUBLE-STRANDED RNA (dsRNA) AND METHOD OF USE FOR INHIBITING EXPRESSION OF A FUSION GENE
03/17/2011	US20110065775 Compounds and methods for modulating expression of sglt2
03/17/2011	US20110065774 Chemically modified oligonucleotides and uses thereof
03/17/2011	US20110065773 Rna interference mediating small rna molecules
03/17/2011	US20110065770 Formulations comprising antisense nucleotides to connexins
03/17/2011	US20110065653 Tat-utrophin as a protein therapy for dystrophinopathies
03/17/2011	US20110065650 Methods of Inhibiting Tumor Cell Proliferation
03/17/2011	US20110065644 Compositions comprising human pcsk9 and apolipoprotein b sirna and methods of use
03/17/2011	US20110065641 Polypeptide and dna thereof useful as a neovascular marker
03/17/2011	US20110065636 Screening and Therapy for Lymphatic Disorders Involving the FLT4 Receptor Tyrosine Kinase (VEGFR-3)
03/17/2011	US20110065596 Directed evolution using proteins comprising unnatural amino acids
03/17/2011	US20110065192 Embryonic stem cell line and method for preparing the same
03/17/2011	US20110065191 Isolated nucleic acids encoding farnesyltransferase polypeptides
03/17/2011	US20110065187 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/17/2011	US20110065186 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/17/2011	US20110065185 Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells
03/17/2011	US20110065182 Modified DNA Cleavage and Methods for Use
03/17/2011	US20110065180 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/17/2011	US20110065179 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
03/17/2011	US20110065178 Dendritic cell potentiation
03/17/2011	US20110065177 Novel Collectin
03/17/2011	US20110065176 Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof
03/17/2011	US20110065175 Artificially synthesized peptide
03/17/2011	US20110065174 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene
03/17/2011	US20110065173 Vector
03/17/2011	US20110065167 Degradation of Hydrophobic Ester Pesticides and Toxins
03/17/2011	US20110065154 Deracemisation of Amines
03/17/2011	US20110065153 Method of producing l-lysine
03/17/2011	US20110065149 Method of producing fused protein

1 ... 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 ... 4023